  |
GE Healthcare T-Piece Circuits for the Giraffe and Panda Resuscitation Systems: Class I Recall – Failure to Achieve the Desired Inspiratory Pressure During Ventilation
AUDIENCE: Emergency Medicine, Pediatrics, Risk Manager
ISSUE: The disposable T-piece circuits do not achieve the maximum positive inspiratory pressure (PIP) levels of 45 +/- cmH2O needed for intense resuscitation. This failure to achieve the desired inspiratory pressure during ventilation may result in inadequate therapy, and the need for additional medical intervention. This product may cause serious adverse health consequences, including death.
BACKGROUND: The T-Piece Resuscitation System is used for the pulmonary resuscitation of infants.
RECOMMENDATION: Customers who have purchased the affected devices were notified by letter with a return receipt dated July 12, 2012. All customers should inspect their stock of T-piece circuits and destroy all circuits with a red inspection stamp. T-pieces with a blue inspection stamp are safe for use.
The recall notice recommends that clinicians do not use a T-piece patient circuit that does not reach the maximum PIP level of 45 +/- cmH2O and always use the built-in Airway Pressure Manometer to verify the PIP value. Healthcare processionals should also continue to emphasize the recommended pre-use checkout practices.
Healthcare professionals and patients are encouraged to report adverse events or side effects related to the use of these products to the FDA's MedWatch Safety Information and Adverse Event Reporting Program:
- Complete and submit the report Online: www.fda.gov/MedWatch/report.htm
- Download form or call 1-800-332-1088 to request a reporting form, then complete and return to the address on the pre-addressed form, or submit by fax to 1-800-FDA-0178
Read the complete MedWatch Safety Alert, including a link to the Firm Press Release, at:
You are encouraged to report all serious adverse events and product quality problems to FDA MedWatch at www.fda.gov/medwatch/report.htm
Update your subscriptions, modify your e-mail address, or stop subscriptions at any time on your Subscriber Preferences Page. You will need to use your e-mail address to log in. If you have questions or problems with the subscription service, please contact support@xxxxxxxxxxxxxxx.
This service is provided to you at no charge by U.S. Food & Drug Administration (FDA).
| This email was sent to list-fda@xxxxxxxxxxx using GovDelivery, on behalf of: U.S. Food & Drug Administration (FDA) · 10903 New Hampshire Ave · Silver Spring, MD 20993 · 800-439-1420 |  |
